http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111065401-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-922 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-28 |
| filingDate | 2018-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111065401-B |
| titleOfInvention | Composition for prevention and treatment of neuromuscular-related diseases including essential oil |
| abstract | The present invention relates to a pharmaceutical composition and a cosmetic pharmaceutical composition for the prevention or treatment of neuromuscular-related diseases, which contain Erigeron annuus essential oil and Botox in combination. The essential oil of P. annua inhibits the formation of t-SNARE protein and v-SNARE protein complex in nerve cell membrane, and inhibits the regeneration of t-SNARE protein and v-SNARE protein degraded by Botox, thereby inhibiting neurotransmitter secretion. The curative effect of Botox can further prolong the duration of the curative effect of Botox, so it can be used as an adjuvant for Botox in combination with Botox to effectively prevent, treat or cosmetically treat neuromuscular-related diseases. |
| priorityDate | 2018-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 204.